SELECTBIO Conferences Emerging Technologies & Paradigms for In Vitro Dx Europe 2024
Emerging Technologies & Paradigms for In Vitro Dx Europe 2024
ÀÏÁ¤ : 2024³â 3¿ù 18-19ÀÏ
°³ÃÖ: Netherlands

‰ï‹c‹c’·

Steve Soper

Steve Soper
Foundation Distinguished Professor; Director, Center of BioModular Multi-scale System for Precision Medicine, Adjunct Professor, Ulsan National Institute of Science & Technology, The University of Kansas

Šî’²u‰‰ŽÒ

Yoon-Kyoung Cho

Yoon-Kyoung Cho
Professor, Biomedical Engineering, Ulsan National Institute of Science & Technology; Group leader, IBS; FRSC, Fellow of Royal Society of Chemistry

Erik Vollebregt

Erik Vollebregt
Partner, Axon Lawyers

Brian Cunningham

Brian Cunningham
Professor and Intel Alumni Endowed Chair, University of Illinois at Urbana-Champaign

Hsian-Rong Tseng

Hsian-Rong Tseng
Professor, Crump Institute for Molecular Imaging, California NanoSystems Institute, University of California-Los Angeles

David Wong

David Wong
Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles

Andrew Godwin

Andrew Godwin
Professor and Division Director, Genomic Diagnostics, Founding Director, Kansas Institute for Precision Medicine, Deputy Director, KU Cancer Center, University of Kansas Medical Center

Paul Bohn

Paul Bohn
Arthur J. Schmitt Professor of Chemical and Biomolecular Engineering and Professor of Chemistry and Biochemistry, University of Notre Dame

Martyn Boutelle

Martyn Boutelle
Professor of Biomedical Sensors Engineering, Imperial College London

Daniel Chiu

Daniel Chiu
A. Bruce Montgomery Professor of Chemistry, University of Washington

ŠT—v

SelectBIO‚́uIn Vitro Dx‚Ì‚½‚߂̐V‚µ‚¢‹Zp‚ƃpƒ‰?ƒC? ‰¢B‘å‰ïi2024”Njv‚ðA2024”N‚RŒŽ18?19“ú‚ɃIƒ‰ƒ“?Eƒƒbƒeƒ‹??‚ÌMarriott Rotterdam‚É‚ÄŠJÃ‚µ‚Ü‚·B

‚±‚̉ï‹c‚ł́AV‚½‚È‘ÌŠOf’f–òi—Տ°Œ»ê‚É•K—v‚È?ƒC?ƒ“ƒO‚Å‹Ÿ‹‹‚³‚ê‚év‘¬f’f–ò‚È‚Ç‚ðŠÜ‚ށj‚ð?’z‚·‚邽‚ß‚Ì‹ZpEƒAƒvƒ??‚ÉŠÖ‚·‚éAŒ»Ý‚Ì‹Zpî¨‚ðÚ×‚É•ªÍ‚·‚邱‚Æ‚ð–Ú•W‚Æ‚µ‚Ä‚¢‚Ü‚·B

‚³‚ç‚ɁAŒ»ÝŠJ”­’†‚Ì‹Zp‚Æ‹¤‚ɏ¤‹Æã‚̐¬Œ÷‚⎸”s‚ÌŠî”Õ‚ð?’z‚·‚é?—ߏãE‹K§ã‚̘g‘g‚݂̃GƒRƒVƒXƒe?‚ɂ‚¢‚ÄŽæ‚è‚Ü‚Æ‚ß‚Ä‚¢‚Ü‚·B

ŽQ‰ÁŠé‹Æ‚ÍŽ©ŽÐ‚Ì‹Zp‚␻•iEƒT?ƒrƒX‚ðŽsê‚ɏЉ‚邱‚Æ‚ª‚Å‚«‚Ü‚·B

¡‰ñ‚̉ï‹c‚ɂ́Aµ‘ҍu‰‰‚âƒX?ƒ“ƒT?Šé‹Æ‚Ì”­?A‚Ü‚½Šé‹Æ‚ª‰ï‹cŽQ‰ÁŽÒ‚Ə¤‹Æ“I‚ÈŠÖŒW‚ð’z‚­‚½‚ß‚Ì‹¤“¯“WŽ¦ƒz?ƒ‹‚à—pˆÓ‚³‚ê‚Ä‚¢‚Ü‚·B

¡‰ñ‚̉ï‹c‚ɂ́Al–¬?¬‚Ì?‰ï‚ª‘½”Ý‚¯‚ç‚ê‚Ä‚¢‚Ü‚·BSelectBIO‚ł́AŽQ‰ÁŽÒ‚ªW‚Ü‚Á‚Đl–¬‚âŠÖŒW«‚ð?‚ß‚éŽè’i‚Æ‚µ‚āA’©H‰ï‚â’‹H‰ïAƒlƒbƒgƒ?ƒLƒ“ƒOƒŒƒZƒvƒVƒ‡ƒ“‚ðŠJÃ‚µ‚Ü‚·B

ŠJÃ‰ïêMarriott Rotterdam‚Ì—§’n‚Í—‘z“I‚ŁAƒƒbƒeƒ‹??’†‰›‰w‚Ì?Œü‚©‚¢‚É‚ ‚èAƒXƒL??ƒ‹‹ó?‚âƒAƒ“ƒgƒ?ƒvAƒuƒŠƒ…ƒbƒZƒ‹AƒpƒŠA‚³‚ç‚ɂ̓ƒ“ƒhƒ“s‚«ƒ†?ƒƒX??‚É‚·‚®Ú‘±‚Å‚«‚Ü‚·B

SelectBIO‚ł́A‚±‚Ì•ª–ì‚̃IƒsƒjƒIƒ“ƒŠ???‚Å‚ ‚éSteve Soper”ŽŽm‚ðA¡‰ñ‚̉ï‹c‚Ì‹c’·‚Æ‚µ‚Ä‚¨?‚¦’v‚µ‚Ü‚·B

?ƒX??•åW

‰ï‹c‚ÉŽQ‰Á‚µ‚È‚ª‚çAŒ¤‹†¬‰Ê‚ð?ƒX??‚Å”­?‚·‚邱‚Æ‚à‚Å‚«‚Ü‚·B‚»‚̏ꍇ‚ÍŠT—v‚ð’ño‚µ‚ĉº‚³‚¢B

?ƒX??‚Ì’ño’÷Ø“úF2024”N3ŒŽ4“ú

ƒAƒWƒFƒ“?‚̃gƒsƒbƒN

  • Circulating Biomarkers: cfDNA, RNA, EVs, Others
    zŠÂƒoƒCƒI??ƒJ?FcfDNAARNAAEV‚È‚Ç

  • Developed Diagnostics Tests -- Cancer Mutation Testing, and Diseases Beyond Cancer Such as CVD and CNS Diseases
    Šù‘¶‚̐f’fŒŸ¸ - ‚ª‚ñ•ÏˆÙŒŸ¸A‚ª‚ñˆÈŠO‚ÌŽ¾Š³iCVDACNSŽ¾Š³‚Ȃǁj

  • Emerging Point-of-Care Diagnostics (POC) Technologies
    V‹K‚ÌPOC (Point-of-Care) f’f‹Zp

  • Emerging Technologies for Developing Dx: Surface-Enhanced Raman, Plasmonics, and Others
    DxŠJ”­‚Ì‚½‚߂̐V‹K‹ZpF?–Ê‘‹­ƒ‰?ƒ“•ªŒõAƒvƒ‰ƒYƒ‚ƒjƒNƒX‚È‚Ç

  • Liquid Biopsy in 2024 -- Status Update
    2024”N‚̉t‘̐¶ŒŸ - ÅVî¨

  • Screening for Early Disease Detection
    Ž¾Š³‚Ì‘Šú”­Œ©‚Ì‚½‚߂̃XƒNƒŠ?ƒjƒ“ƒO

ƒX?ƒ“ƒT?Eo“W‚ɂ‚¢‚Ä

Ú×‚́A (Š”) ƒOƒ?ƒoƒ‹ƒCƒ“ƒtƒHƒ?ƒVƒ‡ƒ“‚Ü‚Å‚¨–â‚¢‡‚킹‚­‚¾‚³‚¢B

u‰‰?’èŽÒiÅVî•ñj

Hyungsoon Im, Assistant Professor, Center for Systems Biology, Mass General Hospital (MGH)/Harvard Medical School


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Choose your language
Traditional Chinese
Simplified Chinese
Japanese
English_